Incannex Healthcare

Incannex Healthcare

Company Headquarters: Melbourne, Victoria, Australia
Company Website: https://www.incannex.com.au/

ABOUT

Incannex is a clinical stage pharmaceutical development company that is developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for the treatment of anxiety disorders, obstructive sleep apnoea (OSA), traumatic brain injury (TBI)/concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis and inflammatory bowel disease. U.S. FDA approval and registration, subject to ongoing clinical success, is being pursued for each drug and therapy under development. Each indication represents major global markets and currently have no, or limited, existing registered pharmacotherapy (drug) treatments available to the public.

Incannex has a strong patent filing strategy in place as it develops its products and therapies in conjunction with its medical and scientific advisory board and partners. Incannex is listed on the Australian Stock Exchange (ASX) with stock code “IHL” and also has American Depository Shares listed on NASDAQ under code “IXHL”.

Company News

Best Cannabis Stocks To Keep An Eye On – July 8th

Best Cannabis Stocks To Keep An Eye

Tilray Brands, Indivior, Canopy Growth, Incannex Healthcare, Turning Point Brands, Aurora Cannabis, and Innovative Industrial Properties are the seven Cannabis

Cannabis Stocks To Keep An Eye On – June 18th

Cannabis Stocks To Keep An Eye On

Aurora Cannabis, Tilray Brands, Quantum Biopharma, Canopy Growth, and Incannex Healthcare are the five Cannabis stocks to watch today, according

Cannabis Stocks To Add to Your Watchlist – June 17th

Cannabis Stocks To Add to Your Watchlist

Quantum Biopharma, Indivior, Canopy Growth, Aurora Cannabis, Incannex Healthcare, Tilray, and Gibraltar Industries are the seven Cannabis stocks to watch